A major European medical device company specializing in ophthalmology has signed a three-year agreement to use TrialMaster EDC from OmniComm Systems, Inc. Under the terms of the agreement, the medical device company has committed to use TrialMaster and related OmniComm services to build and manage multiple clinical studies. The device company selected TrialMaster for a variety of reasons, including OmniComm's user-friendly technology and customer service. The Data Management staff valued TrialMaster's advanced functionality, which will enable them to access image exams through programmable hyperlinks in individual fields in the CRF. Additionally, imaging metadata can be batch loaded into TrialMaster, removing the need for redundant data entry. The device company also appreciated TrialMaster's ease of use for sites, along with the simplicity of the study design tools, which are important factors since the research team will build its own studies in TrialMaster.